1st June, 2022

Phupinder Gill, a former chief executive of CME Group, has taken a role at a new medical derivatives exchange that applied for US approval on Tuesday
Go beyond this article with 1 month’s free, no obligation access to FOW Intelligence — bringing you expert insights and analysis backed by our comprehensive volumes database. Everything you need to stay informed and make smarter decisions.